MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer

Cell

Volumn 113, Issue 2, 2003, Pages 207-219

  Fujita, Naoyuki ^a   Jaye, David L ^a   Kajita, Masahiro ^a   Geigerman, Cissy ^a   Moreno, Carlos S ^a   Wade, Paul A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GENE PRODUCT; PROTEIN MTA3; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; CYTOARCHITECTURE; GENE EXPRESSION; GENE FUNCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; MESENCHYME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPRESSOR GENE; TUMOR DIFFERENTIATION;

GASTROPODA;

EID: 0037453706     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00234-4     Document Type: Article

References (48)

1. Adams C.L., Nelson W.J. Cytomechanics of cadherin-mediated cell-cell adhesion. Curr. Opin. Cell Biol. 10:1998;572-577.
2. Armstrong J.A., Bieker J.J., Emerson B.M. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell. 95:1998;93-104.
3. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:2000;84-89.
4. Behrens J., Mareel M.M., Van Roy F.M., Birchmeier W. Dissecting tumor cell invasion. epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion J. Cell Biol. 108:1989;2435-2447.
5. Blanco M.J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., Nieto M.A. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 21:2002;3241-3246.
6. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:2000;76-83.
7. Ch'ng Q., Kenyon C. egl-27 generates anteroposterior patterns of cell fusion in C. elegans by regulating Hox gene expression and Hox protein function. Development. 126:1999;3303-3312.
8. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22:1999;98-101.
9. Couse J.F., Korach K.S. Estrogen receptor null mice. what have we learned and where will they lead us? Endocr. Rev. 20:1999;358-417.
10. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
11. Fujita N., Shimotake N., Ohki I., Chiba T., Saya H., Shirakawa M., Nakao M. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol. Cell. Biol. 20:2000;5107-5118.
12. Gruber C.J., Tschugguel W., Schneeberger C., Huber J.C. Production and actions of estrogens. N. Engl. J. Med. 346:2002;340-352.
13. Hajra K.M., Fearon E.R. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer. 34:2002;255-268.
14. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62:2002;1613-1618.
15. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
16. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:1998;333-339.
17. Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y., Howard B.H. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 276:2001;6817-6824.
18. Imhof B.A., Vollmers H.P., Goodman S.L., Birchmeier W. Cell-cell interaction and polarity of epithelial cells. specific perturbation using a monoclonal antibody Cell. 35:1983;667-675.
19. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191.
20. Kehle J., Beuchle D., Treuheit S., Christen B., Kennison J.A., Bienz M., Muller J. dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science. 282:1998;1897-1900.
21. Kurdistani S.K., Robyr D., Tavazoie S., Grunstein M. Genome-wide binding map of the histone deacetylase Rpd3 in yeast. Nat. Genet. 31:2002;248-254.
22. Lapidus R.G., Nass S.J., Davidson N.E. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J. Mammary Gland Biol. Neoplasia. 3:1998;85-94.
23. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schotz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily. the second decade Cell. 83:1998;835-839.
24. Masood S. Estrogen and progesterone receptors in cytology. a comprehensive review Diagn. Cytopathol. 8:1992;475-491.
25. Mazumdar A., Wang R.A., Mishra S.K., Adam L., Bagheri-Yarmand R., Mandal M., Vadlamudi R.K., Kumar R. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3:2001;30-37.
26. McDonnell D.P., Norris J.D. Connections and regulation of the human estrogen receptor. Science. 296:2002;1642-1644.
27. McDonnell D.P., Wijayaratne A., Chang C.Y., Norris J.D. Elucidation of the molecular mechanism of action of selective estrogen receptor modulators. Am. J. Cardiol. 90:2002;35F-43F.
28. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
29. Nie Z., Xue Y., Yang D., Zhou S., Deroo B.J., Archer T.K., Wang W. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol. Cell. Biol. 20:2000;8879-8888.
30. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81:2001;1535-1565.
31. Pencil S.D., Toh Y., Nicolson G.L. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res. Treat. 25:1993;165-174.
32. Prall O.W., Rogan E.M., Sutherland R.L. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 65:1998;169-174.
33. Reddel R.R., Sutherland R.L. Tamoxifen stimulation of human breast cancer cell proliferation in vitro. a possible model for tamoxifen tumour flare Eur. J. Cancer Clin. Oncol. 20:1984;1419-1424.
34. Solari F., Bateman A., Ahringer J. The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development. 126:1999;2483-2494.
35. Sommer S., Fuqua S.A. Estrogen receptor and breast cancer. Semin. Cancer Biol. 11:2001;339-352.
36. Sporn M.B. The war on cancer. Lancet. 347:1996;1377-1381.
37. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2:2002;442-454.
38. Toh Y., Pencil S.D., Nicolson G.L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269:1994;22958-22963.
39. Toh Y., Oki E., Oda S., Tokunaga E., Ohno S., Maehara Y., Nicolson G.L., Sugimachi K. Overexpression of the MTA1 gene in gastrointestinal carcinomas. correlation with invasion and metastasis Int. J. Cancer. 74:1997;459-463.
40. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature. 395:1998;917-921.
41. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
42. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T.et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
43. Wade P.A., Jones P.L., Vermaak D., Wolffe A.P. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr. Biol. 8:1998;843-846.
44. Wade P.A., Gegonne A., Jones P.L., Ballestar E., Aubry F., Wolffe A.P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:1999;62-66.
45. Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 10:1996;2117-2130.
46. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell. 2:1998;851-861.
47. Zhang Y., LeRoy G., Seelig H.P., Lane W.S., Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell. 95:1998;279-289.
48. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1999;1924-1935.